首页> 外文期刊>Cardiology >Ultrafiltration in diuretic-resistant volume overload in nephrotic syndrome and patients with ascites due to chronic liver disease.
【24h】

Ultrafiltration in diuretic-resistant volume overload in nephrotic syndrome and patients with ascites due to chronic liver disease.

机译:肾病综合征和慢性肝病腹水患者的利尿剂抗容量超负荷超滤。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Patients with nephrotic syndrome and those with cirrhosis are predisposed to salt and water retention due to reduced renal sodium excretion. Despite the prescription of low-sodium diets and diuretics, some patients develop refractory oedema. When other medical treatments have been ineffective, isolated ultrafiltration and hemofiltration have been successfully used to treat refractory nephrotic patients. Following fluid removal, patients become responsive to diuretics. In cirrhotic patients, re-infusion of ascites and paracentesis with albumin infusion have been reported to be equally effective in managing ascites refractory to diuretic and other standard therapies. Although isolated ultrafiltration has not been successful in controlling ascitic fluid, hemofiltration has been shown to be beneficial, whereas standard intermittent hemodialysis has been reported to be ineffective.
机译:肾病综合症患者和肝硬化患者由于肾钠排泄减少而倾向于保留盐和水。尽管开了低钠饮食和利尿剂的处方,但一些患者仍出现难治性水肿。当其他药物治疗无效时,分离的超滤和血液滤过已成功用于治疗难治性肾病患者。排液后,患者对利尿剂有反应。据报道,在肝硬化患者中,腹水和穿刺穿刺术再输注白蛋白在治疗利尿剂和其他标准疗法难治性腹水方面同样有效。尽管分离的超滤未能成功控制腹水,但血液过滤已被证明是有益的,而据报道标准的间歇性血液透析无效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号